Global Healthcare Private Equity and M&A Report 2021 Global Healthcare Private Equity and M&A Report 2021 State of the Market Gesundheitswesen Welcome Letter: Fertile Conditions for Healthcare Private Equity Investment Stiffer competition raises the bar for generating attractive returns. Gesundheitswesen Healthcare Private Equity Market 2020: The Year in Review Despite new uncertainties, the healthcare profit pool showed remarkable resilience. Gesundheitswesen The Covid-19 Paradox: Widespread Repercussions for Demand, but New Healthcare Investment Opportunities as Well Three demand scenarios can inform investment strategies. Gesundheitswesen Healthcare M&A: A Pandemic-Induced Slowdown in Every Sector Category leadership should continue to motivate many acquisitions. Gesundheitswesen Healthcare Exit Activity: Robust Capital Markets Spur a Surge of IPOs Holding periods held steady, though quick flips remained popular. Gesundheitswesen Healthcare Private Equity Outlook: 2021 and Beyond What are the implications of “healthcare as national defense”? Geographic trends Gesundheitswesen Healthcare Private Equity in North America: Bring On the Gem Assets After a mild decline in deals, activity has started to bounce back on the strength of favorable underlying trends. Gesundheitswesen Healthcare Private Equity in Europe: Steady Dealmaking despite Many Deferrals Investors seek out platforms in retail health and specialty pharma companies. Gesundheitswesen Healthcare Private Equity in Asia-Pacific: Riding a Wave of Domestic Innovation Investors see underserved demand and favorable shifts in healthcare policies. Sector trends Gesundheitswesen Healthcare Providers: New Roll-Up Candidates and a New Look for Risk-Bearing Providers Consolidation accelerates in fragmented segments such as behavioral health, women’s health, and retail health. Gesundheitswesen Healthcare Payers: A Bid to Reduce Costs for Patients and Employers The most successful companies have been able to demonstrate an ROI for both groups. Gesundheitswesen Biopharma: Commercialization Support Services Are Thriving Other private equity deal themes range from modernizing clinical trials to cell and gene therapy. Gesundheitswesen Medtech: Four Themes Fueled Deals despite the Pandemic Covid-19 caused patient volumes to plummet and squeezed supply chains. Gesundheitswesen Healthcare IT: Technologies Help Improve Patient Experiences at Lower Costs Big data analytics to modernize clinical trials also drew investor interest.
